Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Premier Biotech Wins FDA Clearance for Drugs of Abuse Assays

Premier Biotech Wins FDA Clearance for Drugs of Abuse Assays

Sep 25, 2018
|
staff reporter

NEW YORK (360Dx) — Premier Biotech said today it has received 510(k) clearance from the US Food and Drug Administration for two additional assays for use on its OralTox oral fluid-based drugs of abuse device.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Nov
10
Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

What's Popular?

In Point-of-Care Testing

  1. COVID-19 Testing Plays Into Abbott's Long-Term Diagnostic Strategy

    Premium

  2. Maxim Biomedical Ramps Up Manufacturing, Completes Validation of 15-Minute SARS-CoV-2 Antigen Test

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.